Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Sirolimus Reduces Size of Angiomyolipoma Tumors
Link ID 2316
Title Sirolimus Reduces Size of Angiomyolipoma Tumors
Url http://www.medscape.com/viewarticle/568582?src=rss
Description The immunosuppressive drug sirolimus led to shrinkage of angiomyolipomata tumors in patients with tuberous sclerosis complex and/or lymphangioleiomyomatosis. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Jan 11, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. FDA Approves Test to Help Diagnose Unknown Primary Tumor Diagnoses
  Pathwork Tissue of Origin Test is a gene expression test using microarray technology to help diagnose the primary site of tumors of unclear origin. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. EGFR Gene Variants Have Gender-Specific Effects on Colon Cancer Survival
  Functional polymorphisms in the gene expressing epidermal growth factor receptor (EGFR) have opposite prognostic implications for male and female patients with metastatic colon cancer, new study findings indicate. Reuters Health Information
Category:   Articles > Hematology-Oncology


3. Management Challenges in an Older Patient With Metastatic Renal Cell Carcinoma
  This challenging case presentation addresses the critical treatment decisions warranted for an older male patient with metastatic renal cell carcinoma. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


4. Scientists Discover Neuroblastoma Gene
  The author discusses new findings about a genetic cause of neuroblastoma.
Medscape Genomic Medicine
Category:   Articles > Hematology-Oncology


5. Survival Benefit with Low-Dose Dexamethasone in Multiple Myeloma
  Using low-dose dexamethasone with lenalinomide instead of high-dose dexamethasone in newly diagnosed multiple myeloma patients confers a significant survival advantage and has less toxicity. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS